Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$41,000.00

Understanding the genesis of the spliced immunopeptidome

FY 2023-24

Summary
Presentation of antigens by major histocompatibility complex (MHC) molecules is a vital process in the life of an organism. Thousands of such antigens are presented on the surface of virtually all cells in our body. Those antigens are protein fragments (or peptides) that are generated following degradation of proteins inside the cell. Collectively, this ocean of peptides is referred to as the immunopeptidome and can be characterized using advanced technologies. Until now, mass spectrometry (MS) technology is the method of choice for the analysis of the immunopeptidome. The current dogma in antigen presentation is that immune T cells can recognize peptides that are encoded by the genome. Unexpectedly, two landmark studies provided evidences that a significant proportion of the immunopeptidome, in human cells, is composed of peptides that are not encoded in the genome. They may be the result of a very poorly understood mechanism referred to as peptide splicing. The potential implications of the presence of spliced peptides for all facets of the immune system biology is very significant, because their presence dramatically widens the repertoire of antigenic peptides presented to the immune system. However, deciphering the composition of the spliced immunopeptidome is very challenging. In fact, spliced peptides are completely unpredictable from genomic information and MS technologies represent so far the only approach to identify them on a global scale. To date, only a handful of researchers worldwide have developed the appropriate resources and expertise to analyse the spliced immunopeptidome. In our group, we recently found that a significant proportion of the immunopeptidome, analyzed in the mouse as model, is composed of such spliced peptides. These discoveries raise the important point that generation and presentation of spliced peptides is a conserved biological process across evolution. Are spliced peptides randomly generated? In fact, very little is known about their genesis. The objective of our research program is to test the hypothesis that genesis of the spliced immunopeptidome is systematically orchestrated by well-defined catalytic processes regulated at multiple levels inside the cell. First, we will investigate the global relationship between peptide splicing and protein conformational changes on a proteome-wide scale. Second, we will assess the contribution of the proteasome catalytic subunits to the global composition of the spliced immunopeptidome. Third, we will evaluate the role of autophagy and other proteases in catalyzing peptide splicing. The long-term objective of our NSERC program is to gain in-depth understanding of how spliced peptides are generated and presented by MHC molecules. This will allow us to predict them, and will ultimately enable the engineering of new biological systems to control their generation and function in immunity.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2020-05232
Name nom
Caron, Etienne
Department département
Pathology and Cell Biology
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2020
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Understanding the genesis of the spliced immunopeptidome
Keyword
immunopeptidome; mass spectrometry; MHC/HLA; proteasome; proteome; spliced peptide
Application summary
Presentation of antigens by major histocompatibility complex (MHC) molecules is a vital process in the life of an organism. Thousands of such antigens are presented on the surface of virtually all cells in our body. Those antigens are protein fragments (or peptides) that are generated following degradation of proteins inside the cell. Collectively, this ocean of peptides is referred to as the immunopeptidome and can be characterized using advanced technologies. Until now, mass spectrometry (MS) technology is the method of choice for the analysis of the immunopeptidome. The current dogma in antigen presentation is that immune T cells can recognize peptides that are encoded by the genome. Unexpectedly, two landmark studies provided evidences that a significant proportion of the immunopeptidome, in human cells, is composed of peptides that are not encoded in the genome. They may be the result of a very poorly understood mechanism referred to as peptide splicing. The potential implications of the presence of spliced peptides for all facets of the immune system biology is very significant, because their presence dramatically widens the repertoire of antigenic peptides presented to the immune system. However, deciphering the composition of the spliced immunopeptidome is very challenging. In fact, spliced peptides are completely unpredictable from genomic information and MS technologies represent so far the only approach to identify them on a global scale. To date, only a handful of researchers worldwide have developed the appropriate resources and expertise to analyse the spliced immunopeptidome. In our group, we recently found that a significant proportion of the immunopeptidome, analyzed in the mouse as model, is composed of such spliced peptides. These discoveries raise the important point that generation and presentation of spliced peptides is a conserved biological process across evolution. Are spliced peptides randomly generated? In fact, very little is known about their genesis. The objective of our research program is to test the hypothesis that genesis of the spliced immunopeptidome is systematically orchestrated by well-defined catalytic processes regulated at multiple levels inside the cell. First, we will investigate the global relationship between peptide splicing and protein conformational changes on a proteome-wide scale. Second, we will assess the contribution of the proteasome catalytic subunits to the global composition of the spliced immunopeptidome. Third, we will evaluate the role of autophagy and other proteases in catalyzing peptide splicing. The long-term objective of our NSERC program is to gain in-depth understanding of how spliced peptides are generated and presented by MHC molecules. This will allow us to predict them, and will ultimately enable the engineering of new biological systems to control their generation and function in immunity.